• 1. Estimates of hydride ion stability in condensed systems: energy of formation and solvation in aqueous and polar-organic solvents
  Craig A. Kelly,David R. Rosseinsky Phys. Chem. Chem. Phys., 2001,3, 2086-2090
• 2. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
• 3. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 4. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 5. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Imidolactams Imidolactams
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Imidolactams

Introduction to 5-Methyl-1H-pyrazol-3-amine (CAS No: 268724-49-8)

5-Methyl-1H-pyrazol-3-amine, identified by its Chemical Abstracts Service (CAS) number 268724-49-8, is a heterocyclic organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the pyrazole class, a structurally diverse group of molecules known for their broad spectrum of biological activities and utility in drug development.

The molecular structure of 5-Methyl-1H-pyrazol-3-amine consists of a five-membered aromatic ring containing two nitrogen atoms, with a methyl group attached at the 5-position and an amine group at the 3-position. This specific arrangement imparts unique electronic and steric properties to the molecule, making it a valuable scaffold for designing novel bioactive agents. The presence of both nitrogen and oxygen-containing functional groups enhances its potential for interaction with biological targets, such as enzymes and receptors.

In recent years, 5-Methyl-1H-pyrazol-3-amine has been extensively studied for its pharmacological properties. Research has demonstrated its role as a key intermediate in the synthesis of various pharmacologically active compounds. Its structural features make it a versatile building block for medicinal chemists, enabling the development of molecules with potential therapeutic applications in multiple disease areas.

One of the most compelling aspects of 5-Methyl-1H-pyrazol-3-amine is its involvement in the development of compounds targeting inflammatory and immunomodulatory pathways. Studies have shown that derivatives of this molecule exhibit significant anti-inflammatory effects by modulating key signaling pathways such as NF-κB and MAPK. These pathways are central to the body's inflammatory response, making them attractive targets for therapeutic intervention in conditions like rheumatoid arthritis, inflammatory bowel disease, and even certain types of cancer.

Furthermore, 5-Methyl-1H-pyrazol-3-amine has been explored in the context of antimicrobial applications. The pyrazole core is known to possess inherent antimicrobial properties, and modifications to this scaffold can enhance these effects. Recent research has highlighted its potential in developing novel antibiotics against drug-resistant bacterial strains. The ability to target bacterial enzymes and metabolic pathways without causing significant toxicity to host cells makes this compound an exciting candidate for further investigation.

The compound's utility extends beyond inflammation and antimicrobial applications. It has also been investigated for its potential role in neuroprotective therapies. Pyrazole derivatives have shown promise in protecting against neurodegenerative diseases such as Alzheimer's and Parkinson's by inhibiting oxidative stress and preventing the aggregation of toxic protein deposits. The amine functionality in 5-Methyl-1H-pyrazol-3-amine allows for further derivatization, enabling the creation of more potent neuroprotective agents.

In addition to its therapeutic potential, 5-Methyl-1H-pyrazol-3-amine plays a crucial role in chemical biology research. Its ability to serve as a scaffold for drug discovery allows researchers to rapidly screen large libraries of derivatives to identify lead compounds with desired biological activities. High-throughput screening (HTS) techniques combined with computational modeling have accelerated the process of identifying promising candidates for further optimization.

The synthesis of 5-Methyl-1H-pyrazol-3-amine itself is an area of active interest. Various synthetic routes have been developed, each offering advantages in terms of yield, purity, and scalability. Modern synthetic methodologies often incorporate green chemistry principles to minimize waste and improve sustainability. These approaches not only enhance the efficiency of production but also align with global efforts to promote environmentally responsible chemical manufacturing.

One particularly noteworthy synthetic route involves the condensation reaction between methyl acetoacetate and hydrazine hydrate under controlled conditions. This method provides a straightforward pathway to 5-Methyl-1H-pyrazol-3-amine with high regioselectivity, ensuring minimal byproduct formation. The reaction can be further optimized using catalysts or alternative solvents to improve overall efficiency.

The analytical characterization of 5-Methyl-1H-pyrazol-3-amine is another critical aspect of its study. Techniques such as nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry (MS), and X-ray crystallography are routinely employed to confirm its identity and purity. These analytical methods provide detailed insights into the molecular structure, helping researchers understand its reactivity and potential interactions with biological targets.

In conclusion, 5-Methyl-1H-pyrazol-3-amine (CAS No: 268724-49-8) is a multifaceted compound with significant potential in pharmaceutical research and drug development. Its unique structural features make it an invaluable scaffold for designing molecules with therapeutic applications across various disease areas. Ongoing research continues to uncover new ways in which this compound can be utilized to address unmet medical needs, highlighting its importance in modern medicinal chemistry.

• 1904-24-1(5-ethyl-1H-pyrazol-3-amine)
• 82560-12-1(3-tert-butyl-1H-pyrazol-5-amine)
• 125144-04-9(5-Amino-1H-pyrazole-3-carbonitrile)
• 126748-58-1(5-Propyl-1H-pyrazol-3-ylamine)
• 126748-59-2(1H-Pyrazol-3-amine,5-pentyl-)
• 56367-26-1(3-butyl-1H-pyrazol-5-amine)
• 94313-67-4(1H-Pyrazole,3-hydrazinyl-5-methyl-, hydrochloride (1:2))
• 91159-73-8(3,4-dimethyl-1H-pyrazol-5-amine)
• 31230-17-8(3-Amino-5-methylpyrazole)
• 56367-24-9(5-(propan-2-yl)-1H-pyrazol-3-amine)